934 related articles for article (PubMed ID: 17712057)
1. Vasopressin dysregulation and hyponatremia in hospitalized patients.
Multz AS
J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
[TBL] [Abstract][Full Text] [Related]
2. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
Rai A; Whaley-Connell A; McFarlane S; Sowers JR
Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
LeJemtel TH; Serrano C
Int J Cardiol; 2007 Aug; 120(1):1-9. PubMed ID: 17346825
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms, risks, and new treatment options for hyponatremia.
Ghali JK
Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
[TBL] [Abstract][Full Text] [Related]
5. Hyponatremia in neurologic patients: consequences and approaches to treatment.
Diringer MN; Zazulia AR
Neurologist; 2006 May; 12(3):117-26. PubMed ID: 16688013
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin excess and hyponatremia.
Pham PC; Pham PM; Pham PT
Am J Kidney Dis; 2006 May; 47(5):727-37. PubMed ID: 16632011
[TBL] [Abstract][Full Text] [Related]
7. The use of vasopressin receptor antagonists in hyponatremia.
Khanna A; Menon MC
Curr Opin Investig Drugs; 2010 Sep; 11(9):1007-14. PubMed ID: 20730695
[TBL] [Abstract][Full Text] [Related]
8. Hyponatremia and hypernatremia: disorders of water balance.
Agrawal V; Agarwal M; Joshi SR; Ghosh AK
J Assoc Physicians India; 2008 Dec; 56():956-64. PubMed ID: 19322975
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
Palm C; Pistrosch F; Herbrig K; Gross P
Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
[TBL] [Abstract][Full Text] [Related]
10. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.
Robertson GL
Am J Med; 2006 Jul; 119(7 Suppl 1):S36-42. PubMed ID: 16843083
[TBL] [Abstract][Full Text] [Related]
11. Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
Patel GP; Balk RA
Clin Ther; 2007 Feb; 29(2):211-29. PubMed ID: 17472815
[TBL] [Abstract][Full Text] [Related]
12. [Current considerations in syndrome of inappropriate secretion of antidiuretic hormone/syndrome of inappropriate antidiuresis].
Velasco Cano MV; Runkle de la Vega I
Endocrinol Nutr; 2010 May; 57 Suppl 2():22-9. PubMed ID: 21130959
[TBL] [Abstract][Full Text] [Related]
13. Neurological impact of vasopressin dysregulation and hyponatremia.
Bhardwaj A
Ann Neurol; 2006 Feb; 59(2):229-36. PubMed ID: 16437573
[TBL] [Abstract][Full Text] [Related]
14. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management.
Miller M
J Am Geriatr Soc; 2006 Feb; 54(2):345-53. PubMed ID: 16460390
[TBL] [Abstract][Full Text] [Related]
15. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
Wong F; Blei AT; Blendis LM; Thuluvath PJ
Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin-receptor antagonists.
Hoorn EJ; Zietse R
Future Cardiol; 2010 Jul; 6(4):523-34. PubMed ID: 20608824
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
Nemerovski C; Hutchinson DJ
Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
[TBL] [Abstract][Full Text] [Related]
18. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
Goldsmith SR
Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin antagonists: role in the management of hyponatremia.
Yeates KE; Morton AR
Am J Nephrol; 2006; 26(4):348-55. PubMed ID: 16837788
[TBL] [Abstract][Full Text] [Related]
20. Lixivaptan, a non-peptide vasopressin V2 receptor antagonist for the potential oral treatment of hyponatremia.
Ghali JK; Zmily HD; Farah JO; Daifallah S
IDrugs; 2010 Nov; 13(11):782-92. PubMed ID: 21046526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
